Histamine H 4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model

Eriko Suwa, Katsunori Yamaura, Manabu Oda, Takao Namiki, Koichi Ueno

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Effects of the histamine H 4 receptor antagonist 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine (JNJ7777120) were examined for 99 days in a long-term experimental model of pruritic dermatitis induced by repeated challenge with 2,4,6-trinitrochlorobenzene (TNCB) in HR-1 mice. Repeated application of TNCB to the back skin of mice elicited frequent scratching behavior and skin lesions at 24 h after challenge and beyond. JNJ7777120 (10 and 30 mg/kg) reduced this scratching behavior and ameliorated the skin lesions in a dose-dependent manner, whereas the histamine H 1 receptor antagonist fexofenadine had no such effect and did not reduce the inflammation score, even though dexamethasone reduced the scratching bouts. Each of the three agents reduced the increase in the serum IgE concentration induced by TNCB, but only JNJ7777120 reduced the number of mast cells in the skin lesions elicited by repeated application of TNCB. These results indicate that treatment with a H 4 receptor antagonist may be effective for amelioration of both skin inflammation and pruritus in patients with allergic dermatitis such as atopic dermatitis.

Original languageEnglish
Pages (from-to)383-388
Number of pages6
JournalEuropean Journal of Pharmacology
Volume667
Issue number1-3
DOIs
Publication statusPublished - 2011 Sep 30
Externally publishedYes

Fingerprint

Picryl Chloride
Haptens
Pruritus
Histamine
Theoretical Models
Inflammation
Skin
fexofenadine
Dermatitis
Atopic Dermatitis
Mast Cells
Immunoglobulin E
Dexamethasone
1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine
Serum

Keywords

  • Atopic dermatitis
  • Histamine H receptor
  • JNJ7777120
  • Mast cell
  • Pruritus
  • Skin inflammation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Histamine H 4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model. / Suwa, Eriko; Yamaura, Katsunori; Oda, Manabu; Namiki, Takao; Ueno, Koichi.

In: European Journal of Pharmacology, Vol. 667, No. 1-3, 30.09.2011, p. 383-388.

Research output: Contribution to journalArticle

@article{8aa213b9a77c4bd789e129140e04a171,
title = "Histamine H 4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model",
abstract = "Effects of the histamine H 4 receptor antagonist 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine (JNJ7777120) were examined for 99 days in a long-term experimental model of pruritic dermatitis induced by repeated challenge with 2,4,6-trinitrochlorobenzene (TNCB) in HR-1 mice. Repeated application of TNCB to the back skin of mice elicited frequent scratching behavior and skin lesions at 24 h after challenge and beyond. JNJ7777120 (10 and 30 mg/kg) reduced this scratching behavior and ameliorated the skin lesions in a dose-dependent manner, whereas the histamine H 1 receptor antagonist fexofenadine had no such effect and did not reduce the inflammation score, even though dexamethasone reduced the scratching bouts. Each of the three agents reduced the increase in the serum IgE concentration induced by TNCB, but only JNJ7777120 reduced the number of mast cells in the skin lesions elicited by repeated application of TNCB. These results indicate that treatment with a H 4 receptor antagonist may be effective for amelioration of both skin inflammation and pruritus in patients with allergic dermatitis such as atopic dermatitis.",
keywords = "Atopic dermatitis, Histamine H receptor, JNJ7777120, Mast cell, Pruritus, Skin inflammation",
author = "Eriko Suwa and Katsunori Yamaura and Manabu Oda and Takao Namiki and Koichi Ueno",
year = "2011",
month = "9",
day = "30",
doi = "10.1016/j.ejphar.2011.05.037",
language = "English",
volume = "667",
pages = "383--388",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Histamine H 4 receptor antagonist reduces dermal inflammation and pruritus in a hapten-induced experimental model

AU - Suwa, Eriko

AU - Yamaura, Katsunori

AU - Oda, Manabu

AU - Namiki, Takao

AU - Ueno, Koichi

PY - 2011/9/30

Y1 - 2011/9/30

N2 - Effects of the histamine H 4 receptor antagonist 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine (JNJ7777120) were examined for 99 days in a long-term experimental model of pruritic dermatitis induced by repeated challenge with 2,4,6-trinitrochlorobenzene (TNCB) in HR-1 mice. Repeated application of TNCB to the back skin of mice elicited frequent scratching behavior and skin lesions at 24 h after challenge and beyond. JNJ7777120 (10 and 30 mg/kg) reduced this scratching behavior and ameliorated the skin lesions in a dose-dependent manner, whereas the histamine H 1 receptor antagonist fexofenadine had no such effect and did not reduce the inflammation score, even though dexamethasone reduced the scratching bouts. Each of the three agents reduced the increase in the serum IgE concentration induced by TNCB, but only JNJ7777120 reduced the number of mast cells in the skin lesions elicited by repeated application of TNCB. These results indicate that treatment with a H 4 receptor antagonist may be effective for amelioration of both skin inflammation and pruritus in patients with allergic dermatitis such as atopic dermatitis.

AB - Effects of the histamine H 4 receptor antagonist 1-[(5-chloro-1H-indol-2-yl)carbonyl]-4-methylpiperazine (JNJ7777120) were examined for 99 days in a long-term experimental model of pruritic dermatitis induced by repeated challenge with 2,4,6-trinitrochlorobenzene (TNCB) in HR-1 mice. Repeated application of TNCB to the back skin of mice elicited frequent scratching behavior and skin lesions at 24 h after challenge and beyond. JNJ7777120 (10 and 30 mg/kg) reduced this scratching behavior and ameliorated the skin lesions in a dose-dependent manner, whereas the histamine H 1 receptor antagonist fexofenadine had no such effect and did not reduce the inflammation score, even though dexamethasone reduced the scratching bouts. Each of the three agents reduced the increase in the serum IgE concentration induced by TNCB, but only JNJ7777120 reduced the number of mast cells in the skin lesions elicited by repeated application of TNCB. These results indicate that treatment with a H 4 receptor antagonist may be effective for amelioration of both skin inflammation and pruritus in patients with allergic dermatitis such as atopic dermatitis.

KW - Atopic dermatitis

KW - Histamine H receptor

KW - JNJ7777120

KW - Mast cell

KW - Pruritus

KW - Skin inflammation

UR - http://www.scopus.com/inward/record.url?scp=80052035797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052035797&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2011.05.037

DO - 10.1016/j.ejphar.2011.05.037

M3 - Article

VL - 667

SP - 383

EP - 388

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -